 |
|
|
| |
Safety of Sofosbuvir-Based Regimens for the Treatment of Chronic HCV
Infection in Patients With Mild or Moderate Renal Impairment
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Francois Durand,1 Stephen Pianko,2 Liyun Ni,3 Shampa De-Oertel,3 John McNally,3 Diana M. Brainard,3 John G. McHutchison,3 Eugene Schiff,4 Massimo Colombo5
1Hôpital Beaujon, University Paris Diderot, Clichy, France; 2Monash Health, Clayton, Victoria, Australia; 3Gilead Sciences, Inc., Foster City, CA; 4Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, FL; 5Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
|
| |
|
|
|
|
|
